Abstract:Nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) is a key transcription factor involved in modulating redox signalling by regulating the expression of a number of antioxidant genes. It is known that both sympathetic hyperactivity and increased oxidative signalling are hallmarks of chronic heart failure (HF). Previous data from our group have shown that site selective deletion of Nrf2 in the rostral ventrolateral medulla (RVLM) increases blood pressure, reduces baroreflex sensitivity and increases renal sympathetic nerve activity (RSNA) in normotensive mice. Moreover, Nrf2 expression is downregulated in the RVLM of HF mice, where its selective viral up regulation improves baroreflex sensitivity and reduces sympathetic tone. In this study we hypothesized that Nrf2 expression is downregulated in all sympathetic neural tissue in HF, and that selective overexpression of Nrf2 in the stellate ganglia would suppress cardiac sympatho‐hyperactivity and arrhythmogenesis in HF. Heart failure was induced by coronary artery ligation in both mice and rats. Terminal experiments were performed 6 weeks post MI. Heart failure was confirmed by echocardiography. Nrf2 protein and message expression were determined by western blot and rt‐PCR, respectively. Markers of oxidative stress within the stellate were determined using a variety of immunofluorescent techniques. Acute terminal experiments (2 % isoflurane) in rats, determined haemodynamic changes to stellate stimulation. Expression of Nrf2 protein and message was significantly down regulated within the stellate ganglia of both male and female mice (Nrf2 Protein: Male‐Sham, 0.65 ± 0.08 (n = 10), Male‐HF, 0.29 ± 0.13 (n = 9), p < 0.01. Female‐Sham, 0.53 ± 0.05 (n = 3), Female‐HF, 0.25 ± 0.04 (n = 3), ratio Nrf2/GAPDH). Nrf2 mRNA: Male‐Sham, 0.98 ± 0.03 (n = 2), Male‐HF, 0.49 ± 0.55 (n = 3), p < 0.05). Increased markers of redox signalling were seen within the stellate ganglia of HF mice, including increased labelling for 3‐Nitrosylation (3‐NT), 4 Hydroxynonenal, 8‐OHdG, and DHE as a marker of superoxide production. We also observed a reduction in Nrf2, and its downstream target NQO1 in the stellate ganglia of HF rats (10 weeks post coronary artery ligation (2% isoflurane), n = 5, sham and HF), a reduction in stellate Nrf2 was correlated with infarct size and ejection fraction. Within the HF group we observed increased haemodynamic changes to stellate stimulation in anaesthetized rats. These data suggest that oxidative signalling is increased and Nrf2 reduced within the stellate ganglia in HF and could open the potential for future therapeutic targets. Upregulation of Nrf2 in the stellate ganglia and the role of stellate ganglia Nrf2 in cardiac sympathetic drive and redox signalling in HF remain to be determined.Support or Funding InformationWork done with support of the NIH (PO‐1 HL62222) and AHA (18POST34030046).This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Regulation of Nrf2 Signaling Pathway in Heart Failure: Role of Extracellular Vesicles and Non-Coding RNAs.

Extracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart Failure

Abstract 555: Exosomal MicroRNAs Contribute to Chronic Heart Failure Through Dysregulating Nuclear Factor Erythroid 2-Related Factor 2/antioxidant Response Element Signaling

Myocardial Infarction-Induced Microrna-Enriched Exosomes Contribute to Cardiac Nrf2 Dysregulation in Chronic Heart Failure

Extracellular Vesicle-Derived Non-Coding RNAs: Key Mediators in Remodelling Heart Failure

Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets

The Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure

The role of Nrf2-mediated pathway in cardiac remodeling and heart failure.

Nrf2 and autonomic dysregulation in chronic heart failure and hypertension

Nrf2-Keap1 in Cardiovascular Disease: Which is the Cart and Which the Horse?

Cardiac Extracellular Vesicles Aggravate Cardiomyocyte Ferroptosis in Myocardial Ischemia-Reperfusion Injury Via Mir-155-5p-nfe2l2 Signaling

Inappropriate Activation of TLR4/NF-B is a Cause of Heart Failure

The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases

Exercise Training Upregulates Nrf2 Protein in the Rostral Ventrolateral Medulla of Mice with Heart Failure.

Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy (Review)

Upregulating Nrf2 in the RVLM ameliorates sympatho-excitation in mice with chronic heart failure.

Nrf2 for a key member of redox regulation: A novel insight against myocardial ischemia and reperfusion injuries

Abstract P152: Exercise Training Upregulates Nrf2 Gene Expression in the RVLM of Mice with Heart Failure

Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.

Targeting the Nrf2 Pathway Against Cardiovascular Disease

Sympathomodulation in Heart Failure: A Role for Stellate Ganglia Nrf2